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Augmented Pulmonary Responses to Acute Ozone Exposure in Obese Mice: 
Roles of TNFR2 and IL-13
Alison Suzanne Williams, Joel Andrew Mathews, David Itiro Kasahara, Lucas Chen, Allison Patricia Wurmbrand, 
Huiqing Si, and Stephanie Ann Shore
Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA
Ba c k g r o u n d: Acute ozone (O3) exposure results in greater inflammation and airway hyper-
responsiveness (AHR) in obese versus lean mice.
oBjectives: We examined the hypothesis that these augmented responses to O3 are the result of 
greater signaling through tumor necrosis factor receptor 2 (TNFR2) and/or interleukin (IL)-13.
Me t h o d s : We exposed lean wild-type (WT) and TNFR2-deficient (TNFR2–/–) mice, and obese 
Cpefat and TNFR2-deficient Cpefat mice (Cpefat/TNFR2–/–), to O3 (2 ppm for 3 hr) either with or 
without treatment with anti–IL-13 or left them unexposed.
re s u l t s: O3-induced increases in baseline pulmonary mechanics, airway responsiveness, and cellu-
lar inflammation were greater in Cpefat than in WT mice. In lean mice, TNFR2 deficiency ablated 
O3-induced AHR without affecting pulmonary inflammation; whereas in obese mice, TNFR2 
deficiency augmented O3-induced AHR but reduced inflammatory cell recruitment. O3 increased 
pulmonary expression of IL-13 in Cpefat but not WT mice. Flow cytometry analysis of lung cells 
indicated greater IL-13–expressing CD4+ cells in Cpefat versus WT mice after O3 exposure. In Cpefat 
mice, anti–IL-13 treatment attenuated O3-induced increases in pulmonary mechanics and inflam-
matory cell recruitment, but did not affect AHR. These effects of anti–IL-13 treatment were not 
observed in Cpefat/TNFR2–/– mice. There was no effect of anti–IL-13 treatment in WT mice.
co n c l u s i o n s: Pulmonary responses to O3 are not just greater, but qualitatively different, in obese 
versus lean mice. In particular, in obese mice, O3 induces IL-13 and IL-13 synergizes with TNF via 
TNFR2 to exacerbate O3-induced changes in pulmonary mechanics and inflammatory cell recruit-
ment but not AHR.
key w o r d s : airway responsiveness, bronchoalveolar lavage, IL-5, inflammation, MIP-3α. Environ 
Health Perspect 121:551–557 (2013).  http://dx.doi.org/10.1289/ehp.1205880 [Online 22 February 
2013]
Ozone (O3), an air pollutant, causes respiratory 
symptoms and reductions in lung function 
(Alexis et al. 2000). O3 is also a trigger for 
asthma: Asthma-related emergency room visits 
increase on days of high ambient O3 (Fauroux 
et al. 2000; Gent et al. 2003). O3 activates 
the innate immune system causing pulmonary 
infiltration with neutrophils and airway hyper-
responsiveness (AHR), a characteristic feature 
of asthma (Garantziotis et al. 2009).
Two-thirds of the U.S. population is obese 
or overweight (National Center for Health 
Statistics 2012), and obesity is a risk fac-
tor for asthma (Shore and Johnston 2006). 
Nevertheless, our understanding of how obe-
sity impacts pulmonary responses to O3 is still 
rudimentary. O3-induced decrements in lung 
function are greater in obese and overweight 
than lean human subjects (Alexeeff et al. 2007; 
Bennett et al. 2007). Obese mice also exhibit 
greater pulmonary inflammation and greater 
AHR than lean mice after acute O3 exposure 
(Johnston et al. 2006; Shore et al. 2003). The 
mechanistic basis for the effect of obesity on 
responses to O3 is unknown.
Tumor necrosis factor-α (TNFα) is 
induced in the lung after O3 exposure and 
has been implicated in responses to acute O3 
exposure (Cho et al. 2001; Matsubara et al. 
2009; Shore et al. 2001; Yang et al. 2005). 
Serum TNFα increases with obesity (Katsuki 
et al. 1998; Williams et al. 2012). TNFα 
promoter poly  morphisms that augment TNFα 
expression are associated with an increased 
obesity-related risk of asthma, especially non-
atopic asthma (Castro-Giner et al. 2009), 
suggesting that TNFα may also be relevant for 
obesity-related asthma. The role of TNFα in 
the augmented responses to acute O3 observed 
in obese mice has not been established.
TNFα binds to two receptors, TNFR1 
and TNFR2, which differ in their ability to 
induce inflammation and apoptosis and in 
their affinity for cleaved versus membrane-
  associated TNFα (Naude et al. 2011). In lean 
mice, O3-induced AHR requires TNFR2 
(Shore et al. 2001), though TNFR1 may also 
play a role (Cho et al. 2001). TNFR2 is also 
required for the innate AHR that is observed 
in obese mice (Williams et al. 2012), but the 
role of TNFR2 in the augmented responses to 
O3 observed in obese mice is not established.
The first purpose of this study was to exam-
ine the hypothesis that TNFR2 is required for 
the augmented response to acute O3 expo-
sure associated with obesity. To examine this 
hypothesis, we bred Cpefat mice that were 
genetically deficient in the TNFR2 recep-
tor (Cpefat/TNFR2–/– mice). Cpefat mice lack 
carboxy  peptidase E (Cpe), an enzyme involved 
in appetite regulation and energy expendi-
ture (Leibel et al. 1997). Lack of Cpe leads 
to obesity (Johnston et al. 2006, 2010). We 
assessed airway responsiveness and pulmonary 
injury and inflammation in Cpefat/TNFR2–/– 
mice along with wild-type (WT), Cpefat, and 
TNFR2–/– mice.
Interleukin (IL)-13 also plays an impor-
tant role in AHR. In mice, exogenous admin-
istration of IL-13 to the lungs results in 
AHR, and IL-13–blocking reagents inhibit 
allergen-  induced AHR (Grunig et al. 1998; 
Wills-Karp et al. 1998). IL-13 may also 
play a role in responses to acute O3 expo-
sure: In lean BALB/c mice, IL-13 deficiency 
reduces O3-induced AHR and inflammation 
(Pichavant et al. 2008; Williams et al. 2008), 
but the role of IL-13 in responses to O3 in 
obese mice is not established. Consequently, 
to examine the hypothesis that IL-13 con-
tributes to obesity-  related differences in the 
response to O3, we measured IL-13 expres-
sion and examined the effects of anti–IL-13 
antibodies in obese and lean mice. Because 
TNF and IL-13 can synergize to promote the 
expression of chemokines that may contribute 
to the effects of O3 (Reibman et al. 2003), we 
examined the effect of anti–IL-13 treatment 
in both TNFR2-sufficient and -deficient mice.
Methods
Animals. This study was approved by the 
Harvard Medical Area Standing Committee 
on Animals. Animals were treated humanely 
and with regard for alleviation of suffering. We 
bred Cpefat/TNFR2–/–, TNFR2–/–, Cpefat, and 
WT mice as previously described (Williams 
et al. 2012). Female mice were on a C57BL/6 
background, were fed standard mouse chow 
diets, and were 10–12 weeks old.
Protocol. We exposed mice to 2 ppm O3 
for 3 hr. Twenty-four hours after exposure, we 
measured pulmonary mechanics and airway 
responsiveness, performed broncho  alveolar 
lavage (BAL), harvested blood by cardiac 
puncture, and collected lungs for preparation 
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of RNA. Controls for these mice were not 
exposed to O3 but were otherwise treated iden-
tically and studied simultaneously. Pulmonary 
mechanics and airway responsiveness for these 
unexposed mice have been previously reported 
(Williams et al. 2012). We treated other mice 
with anti–IL-13 antibody (2 µg/g body weight 
intraperitoneally) 24 hr before O3 expo-
sure. In a final cohort of O3-exposed mice, 
we harvested lungs at 24 hr, enzymatically 
digested the lungs, and isolated lung cells for 
flow cytometry to quantitate IL-13–expressing 
CD4+ cells.
Measurement of pulmonary mechanics 
and airway responsiveness. We generated quasi 
static pressure volume (PV) curves, assessed 
baseline pulmonary mechanics using the forced 
oscillation technique, and measured airway 
responsiveness to aerosolized methacholine as 
previously described (Williams et al. 2012). 
We assessed Newtonian resistance (Rn), which 
largely reflects the resistance of the conduct-
ing airways, and the coefficients of lung tissue 
damping (G) and lung tissue elastance (H), 
which reflect changes in the small airways and 
pulmonary parenchyma.
Bronchoalveolar lavage. We lavaged lungs 
and counted BAL cells as previously described 
(Williams et al. 2012). We measured BAL 
cytokines, chemokines, and hyaluronan by 
ELISA (R&D Systems Inc., Minneapolis, 
MN; eBioscience, San Diego, CA; and 
Echelon Biosciences, Salt Lake City, UT). 
We measured BAL protein by Bradford assay 
(BioRad, Hercules, CA).
RNA extraction and real­time polymerase 
chain reaction (PCR). We used real-time 
PCR to quantitate IL-13 and IL-17A mRNA 
expression as described (Shore et al. 2011). We 
subtracted Ct values for a housekeeping gene, 
36B4 (rplp0) (which codes for a ribosomal 
protein), from Ct values for IL-13 or IL-17A 
to obtain ΔCt values. We expressed changes in 
mRNA relative to values from the WT unex-
posed mice, using the ΔΔCt method.
Flow cytometry. We flushed the lungs 
to remove blood cells, and then excised, 
minced, and digested lung tissue as previously 
described (Kasahara et al. 2012). We cul-
tured lung cells either with or without PMA 
(phorbol myristate acetate) and ionomycin, 
in the presence of Golgi Stop (BD Bioscience, 
Franklin Lakes, NJ), for 5 hr before stain-
ing for flow cytometry. Cells were fixed with 
4% para  formaldehyde, permeabilized with 
0.1% Triton X-100, incubated with anti-
Fcγ blocking mAb (clone 93; Biolegend, San 
Diego, CA), and washed. We stained the cells 
with Alexa Fluor 488-conjugated CD4 mAb 
(clone GK1.5; Biolegend) and Alexa Fluor 
647-conjugated anti-mouse IL-13 (clone 
eBio13A; eBioscience). We passed the cells 
through a BD Canto flow cytometer (BD 
Bioscience), and analyzed the data with FlowJo 
software (Tree Star Inc., Ashland, OR).
Statistics. We used factorial analysis of 
variance to assess the significance of differ-
ences in outcome indicators, as previously 
described (Williams et al. 2012). We per-
formed analyses using Statistica version 6 
(StatSoft, Tulsa, OK).
Results
Body mass. There was a significant effect of 
Cpe (p < 0.001) but not TNFR2 genotype on 
body mass. Whether or not they were defi-
cient in TNFR2, Cpefat mice weighed about 
twice as much as lean controls, consistent with 
previous observations (Williams et al. 2012).
Pulmonary mechanics and airway respon­
siveness. In WT mice, no significant dif-
ferences in the PV curve of the lungs were 
observed in O3-exposed versus unexposed 
mice (Figure 1A). However, in Cpefat mice, 
there was a rightward shift and widening of 
the PV loop indicative of increased hystere-
sis in O3-exposed versus unexposed mice 
(Figure 1B). To quantitate these changes, 
we measured the area of the PV loop, and 
normalized it by A, the difference in volume 
Figure 1. O3-induced changes in pulmonary mechanics of mice 24 hr after O3 exposure. Mice were unexposed, exposed to O3, or treated with anti–IL-13 24 hr before 
O3 exposure. Pressure volume (PV) curves of WT (A) and Cpefat (B) mice. The areas of the PV curves were normalized for volume A (the differences between total 
lung capacity and end expiratory volume, i.e., the height of the PV curves) (C), baseline values for airway resistance (Rn) (D), the coefficient of lung tissue damping, 
G (E), and the coefficient of lung tissue elastance, H (F). Values shown are mean ± SE of data from 6–9 mice in each group. 
*p < 0.05, compared with unexposed genotype-matched mice. **p < 0.05, compared with TNFR2 genotype-matched lean mice with the same exposure. #p < 0.05, compared with 
O3-exposed genotype-matched mice not treated with anti–IL-13.
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between total lung capacity and end expira-
tory lung volume (height of the PV loops in 
Figure 1). Area/A is a measure of the thickness 
of the PV loop. A was lower in obese versus 
lean mice, as previously reported (Williams 
et al. 2012), but there was no difference in A 
in O3-exposed versus unexposed mice (data 
not shown). Consistent with the increased 
hysteresis induced by O3 in Cpefat but not 
WT mice (Figure 1A,B), Area/A was greater 
in O3-exposed versus unexposed Cpefat mice, 
whereas O3 had no effect on Area/A in WT 
mice (Figure 1C). Area/A was also greater 
in O3-exposed versus unexposed Cpefat/
TNFR2–/– mice (Figure 1C).
Even in unexposed mice, baseline Rn, G, 
and H were elevated in the lungs of obese 
mice (Figure 1D,E,F). O3 exposure had no 
effect on Rn in mice of any genotype, but 
O3 exposure increased baseline G and H in 
Cpefat mice (Figure 1D,E,F). In contrast, no 
significant changes in baseline G and H were 
observed in O3-exposed versus unexposed 
Cpefat/TNFR2–/– mice.
Airway responsiveness was greater in 
un  exposed Cpefat versus WT mice, and this 
difference was abolished by TNFR2 deficiency 
(see Williams et al. 2012). In lean WT mice, 
O3 exposure caused AHR (Figure 2A). This 
effect of O3 was observed when G, a measure 
of the lung tissue response, was used as the 
outcome indicator (Figure 2A). A similar trend 
was observed for H, but did not reach statisti-
cal significance [see Supplemental Material, 
Figure S1 (http://dx.doi.org/10.1289/
ehp.1205880)]. There was no effect of O3 
on methacholine-induced changes in Rn 
(see Supplemental Material, Figure S1A). 
O3-induced AHR was absent in TNFR2–/– 
mice (Figure 2B). O3 did cause AHR in Cpefat 
mice (Figure 2C), and the magnitude of the 
O3-induced AHR was significantly greater 
than in WT mice. O3 also induced AHR in 
Cpefat/TNFR2–/– mice (Figure 2D). Indeed, 
O3-induced AHR was actually greater in 
Cpefat/TNFR2–/– than in Cpefat mice, and 
O3-induced AHR was observed even when 
changes in Rn were used as the outcome indi-
cator, whereas this was not the case in mice 
of any other genotype (see Supplemental 
Material, Figure S1D). O3-induced AHR 
was also observed in Cpefat/TNFR2–/– and 
Cpefat mice when H was used as the index 
of response, and AHR based on changes in 
H was also greater in Cpefat/TNFR2–/– than 
in Cpefat mice (see Supplemental Material, 
Figure S1G,H).
Because IL-13 has been shown to con-
tribute to O3-induced AHR in lean BALB/c 
mice (Pichavant et al. 2008; Williams et al. 
2008), we determined whether there were 
obesity- and/or TNFR2-dependent differences 
in IL-13 expression. O3 caused an increase 
in IL-13 mRNA in obese but not lean mice 
(Figure 3A). There was a nonsignificant trend 
toward increased IL-13 mRNA expression in 
Cpefat/TNFR2–/– versus Cpefat mice. O3 expo-
sure also increased BAL IL-13 in Cpefat but 
not WT mice (Figure 3B). Furthermore, both 
the percentage and the total number of IL-13–
expressing CD4+ cells were higher in Cpefat 
than WT mice exposed to O3 (Figure 3D,E). 
Consequently, we also measured BAL con-
centrations of another Th2 cytokine, IL-5. 
O3-induced increases in IL-5 were significantly 
greater in obese versus lean mice, and TNFR2 
deficiency significantly increased BAL IL-5 
levels in obese but not lean mice (Figure 3F), 
consistent with the trend observed for IL-13 
(Figure 3B). IL-17A has also been linked to 
AHR (Kudo et al. 2012). O3 exposure caused 
a significant increase in IL-17A mRNA in 
obese but not lean mice (Figure 3G). There 
was a nonsignifi  cant trend toward greater 
IL-17A in Cpefat/TNFR2–/– than Cpefat mice.
To examine the functional impact of this 
IL-13 expression, we treated mice with anti-
bodies to IL-13. In WT mice, there was no 
effect of anti–IL-13 treatment, likely because 
pulmonary IL-13 was negligible in these mice 
(Figure 3A,B). In Cpefat mice, anti–IL-13 
treatment reversed the effects of O3 exposure 
on the PV curve (Figure 1B,C), and it pre-
vented the O3-induced increase in baseline 
G and H (Figure 1 E,F) but did not affect 
O3-induced AHR (Figure 2C). In Cpefat/
TNFR2–/– mice, anti–IL-13 treatment also 
prevented O3-induced changes in the PV 
curve (Figure 1C) but had no effect on base-
line pulmonary mechanics or O3-induced 
AHR (Figure 2D).
Pulmonary inflammation and injury. 
O3 exposure significantly increased BAL 
macrophages, neutrophils, and protein [a 
marker of O3-induced injury (Bhalla 1999)] 
(Figure 4). Lymphocytes and eosinophils 
were not observed in BAL fluid of most mice 
regardless of exposure, genotype, or obesity 
status. BAL neutrophils and protein were 
increased in Cpefat versus WT mice exposed 
to O3 (Figure 4). In lean mice, TNFR2 
deficiency had no effect on these responses 
to O3. However, in obese mice, BAL neu-
trophils and macrophages, but not BAL 
Figure 2. Airway responsiveness of mice 24 hr after exposure. Mice were unexposed, exposed to O3, or 
treated with anti–IL-13 24 hr before O3 exposure. Methacholine-induced changes in G, a measure of the 
lung tissue response in WT (A), TNFR2–/– (B), Cpefat (C), and Cpefat/TNFR2–/– (D) mice. Values shown are 
mean + SE of data from 6–9 mice per group. 
*p < 0.05, O3-exposed compared with unexposed genotype-matched mice. **p < 0.05, compared with TNFR2 genotype-
matched mice with the same exposure. #p < 0.05, compared with obesity-matched TNFR2-sufficient mice with the same 
O3 exposure. ##p < 0.05, compared with O3-exposed genotype-matched mice not treated with anti–IL-13.
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protein, were significantly reduced in TNFR2-
deficient versus -sufficient mice (Figure 4). 
The TNFR2-dependent changes in neutrophil 
recruitment were not the result of differences 
in the expression of IL-6, KC (keratinocyte 
chemoattractant), or G-CSF (granulo  cyte col-
ony stimulating factor) [Figure 5A; see also 
Supplemental Material, Figure S2 (http://
dx.doi.org/10.1289/ehp.1205880)], cyto  kines 
and chemo  kines reported to be important for 
O3-induced neutrophil recruitment to the 
lungs (Johnston et al. 2005a, 2005b; Kasahara 
et al. 2012). These chemokines were greater in 
O3-exposed obese versus lean mice, but they 
were either not affected (i.e., IL-6 and KC) or 
actually augmented (i.e., G-CSF) by TNFR2 
deficiency in obese mice. Similarly, TNFR2-
dependent changes in macrophage recruit-
ment are not the result of changes in MCP-1, 
a chemokine required for O3-induced macro-
phage recruitment (Zhao et al. 1998). BAL 
MCP-1 was greater in obese versus lean mice, 
but TNFR2 deficiency had no effect on BAL 
MCP-1 (Figure 5B). Surprisingly, O3-induced 
increases in BAL TNFα were significantly 
reduced in obese versus lean mice (Figure 5C).
O3 induces fragmentation of the matrix 
glycoprotein, hyaluronan, leading to AHR 
(Garantziotis et al. 2009). Such hyal  uronan 
fragments are thought to be induced via oxi-
dative stress caused by O3. O3 exposure caused 
an increase in BAL hyaluronan (Figure 5D) 
as well as protein carbonyls (Figure 5E), a 
marker of oxidative stress, although protein 
carbonyls were only increased in obese and 
not lean mice. Furthermore, O3-induced 
increases in BAL hyaluronan and protein 
carbonyls were significantly greater in obese 
than lean mice (Figure 5D,E), suggesting 
Figure 3. IL-13 mRNA expression in lungs (A) and IL-13 concentration in BAL (B) from mice that were either unexposed or exposed to O3. Example of flow cytom-
etry data from one Cpefat mouse (C) showing histograms of CD4+ lung cells stained with isotype control antibody or stained with anti–IL-13 and either unstimulated 
or stimulated with PMA (10 ng/mL) and ionomycin (500 ng/mL) for 5 hr to induce cytokine expression. Shown also are the percentages (D) and total number (E) of 
PMA and ionomycin stimulated CD4+ cells isolated from lungs of O3-exposed mice that expressed IL-13. BAL IL-5 concentrations (F) and IL-17A mRNA expression 
(G) in unexposed and O3-exposed mice. Values shown are mean ± SE of data from 4–8 mice per group. Results for IL-13 and IL-17A mRNA are normalized to 36B4 
expression. 
*p < 0.05, compared with unexposed genotype-matched mice. **p < 0.05, compared with TNFR2 genotype-matched lean mice with the same exposure. #p < 0.05, compared with obesity-
matched TNFR2-sufficient mice with the same O3 exposure.
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Figure 4. Macrophages (A), neutrophils (B), and protein (C) in BAL from mice that were unexposed, exposed to O3, or treated with anti–IL-13 24 hr before O3 expo-
sure. Values shown are mean ± SE of data from 4–9 mice per group. 
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that elevations in BAL hyaluronan may con-
tribute to greater O3-induced AHR in obese 
versus lean mice. However, BAL hyaluronan 
does not appear to account for the greater 
O3-induced AHR in Cpefat/TNFR2–/– versus 
Cpefat because BAL hyaluronan was not dif-
ferent in these two strains (Figure 5D).
In Cpefat mice, anti–IL-13 treatment 
reduced O3-induced increases in BAL neutro-
phils and macrophages (Figure 4A,B), but not 
BAL protein (Figure 4C), whereas there was 
no effect of anti–IL-13 treatment in Cpefat/
TNFR2–/– mice (Figure 4A,B). O3-induced 
increases in MIP-3α (CCL20; macrophage 
inflammatory protein 3 a) and LIX (CXCL5; 
lipopolysaccharide-induced CXC chemokine) 
mRNA are reduced in IL-13–deficient versus 
WT BALB/c mice, suggesting that changes 
in these chemokines may contribute to the 
effects of IL-13 deficiency on inflamma-
tory cell recruitment (Williams et al. 2008). 
O3-induced increases in BAL LIX, a neutro-
phil chemotactic factor, were not affected by 
obesity, TNFR2 deficiency, or anti–IL-13 
treatment (Figure 6A) indicating that this 
chemokine does not account for the observed 
effects on BAL neutrophils (Figure 4B). 
However, TNFR2 deficiency did attenuate 
O3-induced increases in MIP-3α regardless of 
obesity status (p < 0.001) (Figure 6B). Anti–
IL-13 also caused a significant reduction in 
MIP-3α in TNFR2-sufficient (p < 0.01) but 
not -deficient mice (Figure 6B), suggesting 
that IL-13 and TNFα synergize in the induc-
tion of MIP-3α after O3 exposure.
Discussion
We observed greater effects of acute O3 
exposure in obese versus lean mice consis-
tent with previous observations (Johnston 
et al. 2006; Shore et al. 2003). Importantly, 
our results also indicated obesity-related 
differences in the mechanisms governing 
the pulmonary effects of O3 (see Table 1 
for summary). In lean mice, TNFR2 defi-
ciency reduced O3-induced AHR but had 
no effect on O3-induced inflammation; 
whereas in obese mice, TNFR2 deficiency 
enhanced O3-induced AHR while attenuating 
O3-induced inflammation (Figures 2,4). In 
Figure 5. BAL G-CSF (A), MCP-1 (B), TNFα (C) hyaluronan (D), protein carbonyls (E) from mice that were either unexposed or exposed to O3. Values shown are 
mean ± SE of data from 4–10 mice per group. 
*p < 0.05, compared with unexposed genotype-matched mice. **p < 0.05, compared with TNFR2 genotype-matched lean mice with the same exposure. #p < 0.05, compared with obesity-
matched TNFR2-sufficient mice with the same O3 exposure.
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Figure 6. BAL LIX (A) and MIP-3α (B) from mice that were unexposed, exposed to O3, or treated with anti–
IL-13 24 hr before O3 exposure. Values shown are mean ± SE of data from 5–8 mice per group. 
*p < 0.05, compared with unexposed genotype-matched mice. **p < 0.05, compared with obesity-matched TNFR2-
sufficient mice with the same O3 exposure. #p < 0.05, compared with O3-exposed genotype-matched mice not treated with 
anti–IL-13.
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Table 1. Effect of IL-13 blockade or TNFR2 deficiency on O3-induced increases in airway responsiveness, 
BAL neutrophil numbers, and pulmonary mechanics in lean and obese mice.
Intervention
Lean mice Obese mice
Airway 
responsiveness
BAL 
neutrophils
Pulmonary 
mechanics
Airway 
responsiveness
BAL 
neutrophils
Pulmonary 
mechanics
IL-13 blockade No change No change No change No change Decrease Decrease
TNFR2 deficiency Decrease No change No change Increase Decrease Decrease
Outcomes (no change, increase, decrease) indicate the qualitative change in the response to O3 relative to the absence 
of IL-13 blockade or TNFR2 deficiency.Williams et al.
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lean mice, IL-13 was not induced by O3, and 
there was no impact of anti–IL-13 treatment 
on responses to O3. However, in obese mice, 
O3 did induce IL-13 expression (Figure 3). 
Importantly, obesity-related differences in 
IL-13 expression accounted for the ability 
of O3 to induce changes in the PV curve of 
lung and to increase baseline G and H in 
obese Cpefat but not lean WT mice (Figure 1). 
IL-13 also contributed to the greater recruit-
ment of inflammatory cells to the lungs of 
Cpefat versus WT mice (Figure 4). Moreover, 
in obese mice, IL-13 and TNFR2 appeared 
to synergize to exacerbate O3-induced inflam-
mation and changes in pulmonary mechan-
ics because anti–IL-13 treatment reduced 
inflammatory cell recruitment and G and H 
in TNFR2-sufficient but not -deficient Cpefat 
mice (Figure 4). MIP-3α expression may have 
contributed to the TNFR2/IL-13 synergy 
that promoted inflammatory cell recruit-
ment because TNFR2 deficiency attenuated 
O3-induced increases in BAL MIP3α in 
untreated mice but not in mice treated with 
anti–IL-13 (Figure 6). Thus, obesity-related 
differences in the induction of IL-13 after O3 
exposure not only confer unique and/or aug-
mented responses to O3 on the obese mice, 
but they also appear to account for some of 
the obesity-related differences in the impact 
of TNFR2 deficiency in obese mice because 
TNFR2 can synergize with IL-13 in obese 
but not lean mice.
Our results demonstrating O3-induced 
AHR in WT but not TNFR2–/– mice (Figure 2) 
confirm previous reports indicating that 
TNFR2 is required for O3-induced AHR in 
lean mice (Cho et al. 2001; Shore et al. 2001). 
Circulating TNFα is increased in obese versus 
lean mice and the innate AHR characteristic 
of obese mice is reduced when these mice are 
TNFR2 deficient (Williams et al. 2012) (the 
unexposed mice in Figure 2C,D). Hence, we 
expected that TNFR2 deficiency might also 
attenuate O3-induced AHR in obese mice and 
might even ablate obesity-  related differences 
in the impact of O3 on AHR. We did observe 
a reduction in O3-induced changes in base-
line pulmonary mechanics in Cpefat/TNFR2–/– 
versus Cpefat mice (Figure 1E,F). However, 
O3-induced AHR was actually greater in Cpefat/
TNFR2–/– versus Cpefat mice (Figure 2). This 
greater O3-induced AHR was not the result of 
greater obesity in the Cpefat/TNFR2–/– mice: 
Body mass was the same in the two groups. 
O3-induced increases in BAL TNFα were 
lower in Cpefat versus WT mice (Figure 5C). 
While this reduction might explain a reduced 
impact of TNFR2 deficiency in obese mice, 
it cannot explain the observed reversal in the 
direction of the impact of TNFR2 deficiency 
on O3-induced AHR.
Because others have reported reduced 
O3-induced AHR in lean IL-13–/– versus WT 
BALB/c mice and greater O3-induced AHR in 
IL-13 transgenic mice (Pichavant et al. 2008; 
Williams et al. 2008), we examined the role 
of IL-13 in O3-induced AHR in obese mice. 
O3 caused a significant increase in pulmonary 
IL-13 mRNA expression and BAL IL-13 in 
Cpefat but not WT mice (Figure 3A,B). CD4+ 
T cells appeared to be the source of this IL-13 
(Figure 3C-E), and another CD4+ T-cell–
derived cytokine, IL-5, was also induced by 
O3 exposure in obese mice (Figure 3F).
To determine whether IL-13 contributed 
to obesity- and/or TNFR2-dependent changes 
in the response to O3, we treated mice with 
anti–IL-13 before O3 exposure. Anti–IL-13 
attenuated the O3-induced increase in the 
hysteresis of the PV curve that was induced 
by O3 exposure in obese mice (Figure 1B,C). 
Lung surfactant is important in limiting lung 
hysteresis and IL-13 reduces the pulmonary 
expression of surfactant protein C (Ito and 
Mason 2010), which is important for the 
surface activity of surfactant. Coupled with 
the observations that O3-induced changes 
in lung hysteresis were not observed in WT 
mice (Figure 1A,C), which lacked IL-13 
(Figure 3), the results suggest that O3 caused 
changes in pulmonary surfactant activity 
in Cpefat mice and that these changes were 
mediated by IL-13. Changes in lung hyster-
esis in obese mice may be aggravated by the 
ability of O3 exposure to cause oxidation of 
phospholipids important for surfactant activ-
ity (Pulfer and Murphy 2004). O3-induced 
changes in baseline G and H, measures of the 
lung tissue, were also ablated by anti–IL-13 
treatment (Figure 1). Thus obesity-related dif-
ferences in the ability of O3 to induce IL-13 
expression (Figure 3) appear to account for 
the ability of O3 to induce changes in base-
line pulmonary mechanics in Cpefat but not 
WT mice. TNFR2 deficiency also reduced 
O3-induced changes in pulmonary mechanics 
in Cpefat mice, and anti–IL-13 treatment had 
no effect on mechanics in Cpefat/TNFR2–/– 
mice (Figure 1), suggesting that synergy 
between IL-13 and TNFR2   contributes to 
these changes.
In contrast to the effects on baseline pul-
monary mechanics (Figure 1), we observed 
no effect of anti–IL-13 treatment on 
O3-induced AHR in Cpefat mice (Figure 2C), 
nor was there any effect on AHR in Cpefat/
TNFR2–/– mice (Figure 2D), indicating that 
the enhanced AHR in Cpefat/TNFR2–/– mice 
was not the result of increased IL-13 signaling. 
Thus, other factors must account for obesi-
ty-related increases in O3-induced AHR and 
for the augmented AHR observed in Cpefat/
TNFR2–/– mice. IL-5 can induce AHR even 
in the absence of eosinophils (Borchers et al. 
2001) (eosinophils were not observed in these 
animals). IL-5 was augmented in O3-exposed 
Cpefat versus WT mice and further augmented 
in Cpefat/TNFR2–/– mice (Figure 3F), con-
sistent with the changes in AHR (Figure 2). 
IL-17A can also induce AHR (Kudo et al. 
2012). IL-17A was expressed after O3 expo-
sure (Figure 3G), especially in the obese mice, 
and could also contribute to the augmented 
O3-induced AHR observed in these mice 
(Figure 2).
In lean mice, TNFR2 deficiency had 
no effect on O3-induced inflammatory cell 
recruitment (Figure 4), consistent with previ-
ous observations (Cho et al. 2001; Shore et al. 
2001). In contrast, in obese mice, TNFR2 
deficiency reduced O3-induced neutrophil 
and macrophage recruitment and ablated 
obesity-related differences in these outcomes 
(Figure 4). Anti–IL-13 treatment also had no 
effect on O3-induced inflammation in lean 
WT mice, which lacked IL-13 (Figure 3A,B), 
but anti–IL-13 treatment significantly reduced 
O3-induced inflammatory cell recruitment 
in obese Cpefat mice (Figure 4A,B). A simi-
lar reduction in O3-induced inflammation 
occurs in lean IL-13–deficient BALB/c mice 
(Williams et al. 2008), which are more Th2 
prone than the C57BL/6 mice used in the 
present study. Importantly, in obese mice, 
TNFR2 and IL-13 appeared to interact 
to promote inflammatory cell recruitment 
because anti–IL-13 treatment had no effect 
on BAL neutrophils or macrophages in Cpefat/
TNFR2–/– mice even though these mice had at 
least as much IL-13 expression as Cpefat mice 
(Figure 4A,B). This interaction may occur at 
the level of MIP-3α expression. In obese Cpefat 
mice, both TNFR2 deficiency and anti–IL-13 
treatment resulted in a significant decrease in 
BAL MIP-3α (Figure 6B), consistent with 
observations of others that TNFα and IL-13 
can both induce the expression of MIP-3α in 
airway epithelial cells (Reibman et al. 2003). 
Importantly, anti–IL-13 treatment inhib-
ited MIP-3α expression in TNFR2-sufficient 
but not -deficient Cpefat mice (Figure 6B). 
Dendritic cells and T cells typically express 
CCR6, the receptor for MIP-3α, but neutro-
phils can be induced to express CCR6 in the 
presence of TNFα (Yamashiro et al. 2000). 
In addition, MIP-3α can induce migration of 
IL-17A expressing cells that may contribute 
to neutrophil recruitment (Li et al. 2011). 
IL-17A was induced by O3 (Figure 3G).
O3-induced changes in lung function 
(i.e., G and H) and cellular inflammation 
occurred in concert (Table 1). O3-induced 
increases in BAL neutrophils and in both G 
and H were greater in Cpefat versus WT mice. 
Furthermore, both TNFR2 deficiency and 
anti–IL-13 treatment reduced O3-induced 
changes in G and H as well as BAL neutro-
phil numbers in obese mice (Table 1). The 
results suggest that effects of O3 on lung func-
tion and inflammation may be mechanisti-
cally related. In contrast, O3-induced AHR TNFR2, IL-13, ozone, and obesity
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and inflammation were dissociated. For 
example, TNFR2 deficiency and anti–IL-13 
treatment either augmented or had no effect 
on O3-induced mice, but they attenuated 
O3-induced inflammation in obese mice.
Two technical issues require consideration. 
First, obese mice have a slightly higher minute 
ventilation (Shore and Johnston 2006) and 
consequently a slightly higher inhaled dose 
of O3. Their lungs are also smaller (Williams 
et al. 2012), so the dose per gram of lung 
tissue may be higher. We do not think this 
issue contributed substantially to the outcome 
because neither TNFR2 deficiency nor 
anti–IL-13 treatment had any effect on lung 
volume (data not shown), but both reduced 
the augmented effects of O3 on BAL cells 
and pulmonary mechanics in obese mice. 
Second, we used the same volume of fluid 
for lavage in obese and lean mice. Because 
the lungs of the obese mice were smaller and 
presumably had correspondingly less lung 
lining fluid, there should have been greater 
dilution of substances in that lining fluid and 
thus lower concentrations of BAL moieties 
in the obese than the lean mice. In fact, the 
opposite was true for most BAL cytokines/
chemokines examined [Figures 3,5,6; 
see also Supplemental Material, Figure S2 
(http://dx.doi.org/10.1289/ehp.1205880)]. 
Thus, issues related to normalization of the 
BAL procedure are unlikely to explain the 
observed results.
Conclusions
Our results indicate differences in the mecha-
nisms regulating pulmonary responses to 
O3 in lean and obese mice. In particular, 
TNFR2 deficiency had opposing effects on 
O3-induced AHR in lean and obese mice. 
In addition, O3 increased the pulmonary 
expression of IL-13 in obese but not lean 
mice, and this IL-13 appeared to account 
for the augmented ability of O3 to induce 
changes in pulmonary mechanics and inflam-
mation in obese mice via synergistic effects 
with TNFR2. The majority of the population 
of the United States is either obese or over-
weight. Our results emphasize the need for 
improved understanding of the effects of O3 
in this population.
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